1 min read
Veranex’s Model Assesses EXENT® GAM Assay* Savings in Myeloma Patient Monitoring
The investigational model considered the use of the EXENT® GAM Assay from the Binding Site, part of Thermo Fisher Scientific. This is a mass...
Commercialization
5 min read
Rescue Studies: Salvaging Clinical Trials Through Expert Data Management
When a clinical trial faces data quality challenges, every day counts. Rescue studies have become an increasingly critical component in preserving...
5 min read
Preparing for a Patent with Bob Bouthillier Director, Electrical Engineering, Veranex
In this post, our director of electrical engineering Bob Bouthillier, director of electrical engineering for Veranex, covers the importance of...
1 min read
Identification, Engagement and Commitment of Key Players for a Successful Preclinical Study
Assembling a team for an efficient preclinical study When it comes to kicking off your preclinical study, assembling the right team will help you...
3 min read
Expert Insights: Project Management with Matt Perry
Recently we sat down with Matt Perry, VP of program management at Veranex, to talk about common project management issues within medtech, and his...
3 min read
Insights Into the Needs of Chinese Hospital Lab Customers
We recently analyzed a report prepared by Ding Xiang Yuan (abbreviated as DXY; Ding Xiang Yuan is one of the largest and most influential online...
2 min read
The New Normal for Market Access in China: Volume Based Procurement
Our previous update1, Analysis of China’s First National Tender on Coronary Stents, discussed the first national-level centralized tender for a...
2 min read
Meet the Team: Soma Sekhar Koramatla, Associate Manager, Statistical Programming, Biometrics
In this installment of our “Meet the Team” blog series, we talk to Soma Sekhar Koramatla, Associate Manager, Statistical Programming, Biometrics...
2 min read
China Reveals Its 2025 Coverage Goals for Publicly Funded Healthcare
In September 2021, China’s National Healthcare Security Administration (NHSA), the government agent in charge of publicly funded healthcare announced...
1 min read
China Aims to Complete Transition to DRG Payment Model for Inpatient Care by 2024
In November 2021, the Chinese government announced its 3-year (2022-2024) payment reform plan with the end goal to fully implement a diagnosis...